Dr. Peloza was one of only a handful of physicians in the country selected to participate in this monumental study gathering data used to support an application to the U.S. Food and Drug Administration (FDA) that could allow the approved future use of the device.
Approximately 200,000 lumbar surgeries are performed in the U.S. every year. These surgeries usually require a spinal fusion often with the use of instrumentation such as rods, screws, and cages. The MAVERICK™ could potentially offer another option to patients suffering from degenerative disc disease. The disc’s design is based on decades of total joint arthroplasty experience.
Degenerative disc disease is part of the natural process of growing older. As people age, their intervertebral discs lose their flexibility, elasticity, and shock absorbing characteristics. Discs are gel-like cushions that act as shock absorbers between each of the bones of the spine. For approximately half of the over-40 population, this process can cause several different symptoms, including back pain, nerve root pathology, and spinal cord compression.
For those people suffering from degenerative disc disease who do not respond to conservative treatment, surgery may be recommended. The most common surgery for treating degenerative disc disease is a spinal fusion. During a fusion procedure, the degenerated disc is removed and a bone graft, taken either from the patient’s iliac crest (hip area), a donor (cadaver) bone, or a bone graft substitute is inserted in between the two vertebrae above and below the removed disc. Often, metal implants are then attached to the two vertebrae to stabilize the area until the bone graft can fuse to the vertebrae creating one solid piece of bone.
Center for Spine Care offers stem cell therapy as a conservative treatment to promote natural healing for back or neck pain. Utilizing mesenchymal stem cells, this new method is used to treat patients with neck and back pain caused from degenerative disc disease.